Release Date: 15/09/10 09:51 Summary: A$150.8 Million Equity Raising to Fund Acquisition of Assets Price Sensitive: Yes Download Document 39.78KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%